Product Information
RISEDRONATE SODIUM 150 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $12.9072 per EA under NDC 65862087011. Its NADAC has been published 514 times since Nov 30, 2016.
FDA first approved this application on Oct 21, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862087011
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RISEDRONATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206768FDA Approved
10/21/2016
TE Code
AB
On Market Since
10/21/2016
Pharmacological Classes
Price Statistics
The NADAC for RISEDRONATE SODIUM 150 MG TAB has been published 514 times since Nov 30, 2016, and over the history we have for it it has declined 86.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.9072 per EA |
|---|---|
| All-time high | $98.4054 (Jan 11, 2017) |
| All-time low | $9.8142 (May 22, 2024) |
| 52-week high | $17.6823 |
| 52-week low | $12.8176 |
| Median price | $31.2938 |
| Average price | $31.7068 |
| Largest weekly change | +58.0% (Aug 21, 2024) |
| Weeks tracked | 514 |
| Tracking since | Nov 30, 2016 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Risedronate Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bisphosphonate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RISEDRONATE SODIUM 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for RISEDRONATE SODIUM 150 MG TAB, manufactured by Aurobindo Pharma Limited, is $12.9072 per EA (NDC 65862087011), effective Sep 30, 2026.
How has the price of RISEDRONATE SODIUM 150 MG TAB changed over time?
Over the history we have for it, the NADAC for RISEDRONATE SODIUM 150 MG TAB has declined 86.1%. It has been tracked across 514 weekly CMS publications since Nov 30, 2016.
What are the highest and lowest recorded NADAC prices for RISEDRONATE SODIUM 150 MG TAB?
Since Nov 30, 2016, the NADAC for RISEDRONATE SODIUM 150 MG TAB has ranged from a low of $9.8142 (May 22, 2024) to a high of $98.4054 (Jan 11, 2017), with a median of $31.2938 per EA.
Are there cheaper alternatives to RISEDRONATE SODIUM 150 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RISEDRONATE SODIUM 150 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures RISEDRONATE SODIUM 150 MG TAB?
RISEDRONATE SODIUM 150 MG TAB (NDC 65862087011) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.